The direct effect of a,-autoreceptors was studied by measuring the effects of piperoxan, an a,-autoreceptor antagonist, and clonidine, an agonist on catecholamine exocytosis, from single bovine chromaffin cells in culture. Catecholamine release was elicited by stimulation with 100 PM nicotine and was monitored electrochemically with a carbon-fiber microelectrode placed adjacent to the cell. These electrodes allowed the number of exocytotic release events to be monitored and reported as total charge for release following a specific stimulus. Repeated stimulation with 100 PM nicotine showed that total release caused by the second exposure to nicotine was 32% of the first, and release caused by the third exposure to nicotine was 80% of the second. Total release of catecholamine increased significantly after application of 20 PM piperoxan relative to a control application of balanced salt solution. Application of 20 @I piperoxan alone did not cause release. After the cells were incubated in culture medium containing 20 MM clonidine, a significant decrease in nicotine-stimulated catecholamine release was observed. These results confirm that there are autoreceptors on chromaffin cells and, when relatively high levels of catecholamine are released, the catecholamine stimulates the a,-autoreceptors, which inhibits subsequent release through a negative feedback mechanism.
In addition to piperoxan, the sympathomimetic drug amphetamine also increases quanta1 release after application of nicotine. Amphetamine increases the extracellular concentration of catecholamine, and these data appear to indicate that at least part of the pharmacology of amphetamine might involve blocking catecholamine autoreceptors. [Key words: a,-autoreceptors, catecholamines, adrenal medullaty chromaffin cells, microelectrodes, piperoxan, clonidine, amphetamine]
The release of catecholamines to the extracellular synaptic cleft can be regulated by several factors, which include presynaptic cY,-autoreceptor activation (Starke, 1981) . The released extra-cellular catecholamines act on presynaptic oc,-autoreceptors to inhibit further catecholamine release (Starke, 1977; Westfall, 1977) and oc,-autoreceptor agonists such as clonidine or guanfacine cause a suppression of locus cell firing and decrease the release of catecholamines (Pelayo et al., 1980; Cooper et al., 199 1; Jackisch et al., 1992) whereas ol,-autoreceptor antagonists such as piperoxan, yohimbine, and idazoxan reverse these inhibitory effects and increase release (Dennis et al., 1987; Abercrombie et al., 1988; Cooper et al., 1991) .
Although some experiments have provided evidence about presynaptic mechanisms, it is not always possible to determine if the drugs affect the presynaptic terminals directly, or whether they act primarily on nearby cells that then emit a second signal to the presynaptic terminals. This is particularly difficult to decide in tissue studies (Starke, 198 1) . Basically, there are two methods to study the interaction of neurotransmitters or drugs with cells. The first procedure is to determine the biological response ofan intact isolated organ, such as the guinea pig ileum, to applied agonists or antagonists. The disadvantage to this procedure lies in the difficulty in discriminating between a large number of processes taking place before the drug interacts with the receptor. The second approach to studying receptors is to measure ligand binding to a homogenate or slice preparation. This technique became feasible with the development of ligands of a high specific radioactivity and a high affinity for the receptor (Cooper et al., 199 1) . Neither of these techniques eliminate postsynaptic effects. The use of amperometric monitoring of catecholamine exocytosis (Leszczyszyn et al., 1990) combined with the application of receptor agonists or antagonists, is a new method that can functionally identify autoreceptors directly, since there are no postsynaptic cells. The electrochemical measurements described here are spatially resolved to the singlecell level because of the size of the microelectrode sensor as well as the small volume of the applied chemical stimulus.
Adrenal medullary chromaffin cells were selected in the present study because they contain secretory granules that store the catecholamine hormones epinephrine and norepinephrine and they are similar to sympathetic neurons in neuroectodermal origin and biochemical function (Douglas, 1968; Viveros, 1975; Wightman et al., 1991) . The cultured adrenal medullary cells have most of the properties of the cells in the intact gland (Wilson and Viveros, 198 1; Livett, 1984) . In the present work we used a new electrochemistry method (Leszczyszyn et al., 1990) , combined with the application of an cu,-autoreceptor antagonist, piperoxan, and an agonist, clonidine (Feldman and Quenzer, 1984; Cooper et al., 199 I) , to investigate the direct effect of +-autoreceptors on nicotine-stimulated release of catecholamines from single adrenal medullary chromaffin cells.
Materials and Methods
Cultured chromajin cells. Primary cultures of bovine adrenal medullary chromaffin cells were prepared as previously described by Wilson and Viveros (198 1) and Leszczyszyn et al. (199 1) from fresh adrenal glands obtained from a local slaughterhouse. Experiments were performed at 37°C between days 4 and 6 ofculture. The culture medium was removed and the cells were washed three times and then maintained in a balanced salt solution containing 150 mM NaCl, 4.2 mM KCl, 1 .O mM NaH,PO,, 11.2 mM glucose, 0.7 mM MgCl,, 2 mM CaCl,, and 10 mM HEPES, adjusted to pH 7.4. MgCl, was substituted for Caz+-free solutions (Wightman et al., 1991) . Chemical stimulations were performed with the desired agent dissolved in this solution.
Electrodes and voltammetricprocedures. Working electrodes were prepared from 5-pm-diameter carbon fibers sealed in glass capillaries (Kelly and Wightman, 1986) . The sensing tip of the electrode was polished at a 45" angle on a micropipette beveler (World Precision Instruments, New Haven, CT). The reference electrode was a sodium-saturated calomel electrode (SSCE). Constant-potential amperometry was performed with a commercial potentiostat (EI-400, Ensman Instrumentation, Bloomington, IN). The applied potential was 650 mV. The output was connected to an A/D converter (Labmaster, Scientific Solutions, Solon, OH) interfaced with a IBM personal computer.
Singlechromajin cell release experiments. The culture dish was placed on the stage of a microscope (IM35, Zeiss, Germany) resting upon a vibration isolation table (Kinetic Systems, Boston, MA). A working electrode was positioned over the top of a cell with a three-dimensional micromanipulator (Narishige, Tokyo, Japan). The electrode was manipulated so that it lightly touched a cell and then was retracted to the desired position (Wightman et al., 199 1) . Release of catecholamine from a single chromaffin cell was induced through short-duration (3 set) local applications of 100 PM nicotine. Both the cu,-autoreceptor antagonist piperoxan and agonist clonidine were used to show the effect of autoreceptors. The antagonist was examined following short-duration (3 set) local application of 100 PM nicotine followed by local application of 20 PM piperoxan or balanced salt solution from two micropipettes attached to a two-channel pressure-application device (Picospritzer, General Valve Corporation, Fairfield, NJ). For the clonidine experiments, the cells were incubated for 30-90 min in the culture medium containing 20 PM clonidine and secretion of catecholamine was elicited through local application of 100 PM nicotine with 20 PM clonidine. Typical tip dimensions of micropipettes were 10 pm. They were calibrated to deliver volumes of approximately 3 nl at 1 sec. The micropipettes were positioned with a micropositioner (Zeiss) 30 pm from the cell.
Data treatment. Transient current responses were evaluated by a peakdetection-integration algorithm. This program evaluated the current response by comparing the difference between consecutive data-point values, which is the first derivative of the original current data. When the difference between consecutive data points is greater than the peakdetection threshold (also called the noise threshold and is dependent on the experiment), then spikes were considered significant. Transient current responses measured in the amperometric mode were integrated with respect to time to determine the amount of charge in units of picocoulombs (PC). The charge in each spike is related to the number of moles electrolyzed by Faraday's law.
Significance testing employed a two-side Student's t test. Reported values are given with the standard error of the mean (SEM).
Results

Nicotine-stimulated catecholamine release from single cells
The response of a single cell to a 3 set application of 100 PM nicotine monitored by amperometry at a microelectrode is shown in Figure 1A . Current responses owing to the release of catecholamine from single granules are rapid and transient, as has been shown previously (Leszczyszyn et al., 1990, 199 1; Wightman et al., 199 1) . The average spike area in our experiments was 0.7 + 0.02 pC (n = 2 18). Oxidation current for catecholamines at a carbon-fiber microelectrode placed adjacent to a single cell in Ca2+-free buffer is shown in Figure IB . In this experiment, an injection of 100 PM nicotine without Ca2+ in either the cell medium or injection pipette resulted in no current spikes. However, a second injection of nicotine with 2 mM Ca*+ in the injection solution evoked a series of rapid current responses.
Repeated nicotine-stimulated catecholamine release from single cells To demonstrate the effect of autoreceptors on quanta1 release in the adrenal cell system, it is preferable to use the response to repeated nicotine stimulations of the same cell. Individual cells were repeatedly stimulated with 3 set exposures to nicotine (100 PM) at intervals of 100400 sec. The current responses for neurohormone secretion were integrated to obtain the total charge for the response over a 200 set time window. Representative data are shown in Figure 2 . For repetitive 3 set exposures to nicotine, the ratio of total secretion of the second to the first exposure (S,:S,) is 0.32 * 0.05 (n = 7) and the ratio of total Figure 3A .
After a 3 set application of nicotine, the characteristic current response showing a large number of oxidation spikes is observed. At approximately 80 set after the stimulation, the occurrence of oxidation spikes has significantly decreased. At this point, application of 20 PM piperoxan results in a significant increase in the oxidation spikes observed. A second 5 set application of 20 PM piperoxan after another 80 set interval again results in oxidation spikes, apparently indicating a resurgence of catecholamine release by exocytosis. Three additional 5 set applications of 20 FM piperoxan resulted in very little increase in oxidation spikes. However, a final application of nicotine resulted a sharp increase in release events as observed by amperometry. A control experiment involving application of nicotine followed by only a balanced salt solution is shown in Figure  3B . The data in Figure 3B are very similar to that obtained following only nicotine stimulation (Fig. 1A) .
To evaluate the effect of piperoxan on catecholamine exocytosis, the integrated current for release events following nicotine and piperoxan together has been compared to the total charge for release events after only nicotine. This comparison is shown as a ratio of the total charge for all the current spikes after the sequence of nicotine and piperoxan stimulations to the total charge after only nicotine in Figure 4 . A 15% (n = 3) increase in catecholamine release is observed after the nicotine and piperoxan compared to a 46% (n = 6) decrease in release for the control experiment (identical protocol without application of piperoxan). 30-90 min and then stimulated with a 3 set injection of nicotine containing 20 FM clonidine. The action of clonidine is slow and has little or no effect on stimulated release after transient application. The comparison between the total charge for catecholamine release events after incubation with clonidine to that of a control group without clonidine is shown in Figure 5 . After incubation with clonidine for 30-60 min, secretion decreases 75% over the control group (P < 0.05). Secretion decreases 82% over the control group (P < 0.05) when a 90 min incubation with clonidine is used.
Eflect of amphetamine on nicotine-stimulated catecholamine release from single cells Amphetamine is thought to act via a mechanism that increases the extracellular concentration ofcatecholamines. Here, we have (Fig. 6) . A comparison of the ratio of total release following nicotine and amphetamine relative to nicotine only is included in Figure 4 . The increase in catecholamine exocytosis (only the current under the current spikes is integrated) over the control experiment is 870%.
Discussion
Voltammetry at microelectrodes can be used to monitor single exocytotic events at catecholamine containing adrenal medullary chromaffin cells (Leszczyszyn et al., 1990, 199 and amphetamine (20 PM) on nicotinestimulated release. In each experiment, a 3 set application of 100 PM nicotine was followed by a 5 set application of balanced salt solution (&KS') (n = 6), 20 PM piperoxan (n = 3) or 20 PM amphetamine (n = 3). Catecholamine release is expressed as the ratio of total charge for all release events (integrated current under all the spikes monitored) following nicotine and balanced salt solution, nicotine and piperoxan, or nicotine and amphetamine, relative to the total charge for all release events following nicotine only. Both piperoxan and amphetamine increase nicotinestimulated release significantly: *, P < 0.05; **, P < 0.01).
et al., 1991). In the previous work, voltammetric and pharmacological evidence indicated that the amperometric signals observed were due to exocytosis of catecholamines. The amperometric response to nicotine stimulation is Ca2+ dependent and consists of a series of rapid current spikes when the electrode is held at a sufficient oxidation potential (Fig. 1) . This is consistent with the requirement of Ca2+ for exocytosis (Douglas, 1968; Viveros, 1975; Schweizer et al., 1989) . Assuming a twoelectron oxidation process, the quantity of charge in the average spike corresponds to the detection of 4 x lo-l8 mol of catecholamine. This value is in the range calculated for the average catecholamine vesicle in adrenal cells (Winkler and Westhead, 1980; Wightman et al., 199 1) . It is apparent from the data in Figure 2 that the total catecontrol 30-60 min !lOmin Figure   5 . Effect of clonidine (20 PM) on nicotine-stimulated catecholamine release. The cells were incubated with clonidine for 30-60 min (n = 4), or 90 min (n = 4) and then stimulated with a 3 set injection of nicotine containing 20 PM clonidine. The current responses for catecholamine release after the first nicotine stimulation were integrated to obtain the total charge. The total release decreased significantly after incubation with clonidine (P < 0.05) as compared to the control stimulations (n = 13). cholamine release (number of release events) from exocytosis following nicotine stimulation diminishes by 68% from the first to the second consecutive stimulation. From the second to the third stimulation only a 20% decrease in total release is observed. As shown below, this cannot be explained simply by depletion of catecholamine vesicles, but rather, appears to be the result of cell inhibition by autoreceptors.
To support the hypothesis that autoreceptors are activated by a threshold concentration of released neurotransmitter, the release of catecholamines has been estimated from overflow into an incubation or perfusion fluid (Langer, 1977; Langer et al., 1977; Starke, 1977 Starke, , 1987 Langer and Dubocovich, 198 1) . The present work provides direct evidence for autoreceptors at the single-cell level and with millisecond time resolution. Although it has been reported that functional adrenoreceptors are not present on adrenal chromaffin cells (Powis and Baker, 1986; Orts et al., 1987) , the results of repeated stimulation (Fig. 2) suggest that cY,-autoreceptors do exist on the adrenal medullary chromaffin cells and act to decrease catecholamine release. The data in Figure 3 strongly suggest that a negative feedback mechanism exists. The first and second injections of piperoxan lead to the promotion of release spikes, but subsequent injections do not result in additional release. Apparently, the effects of the initial nicotine stimulation on the nicotinic receptors are diminished at these later times. Exposure to piperoxan enhances the release of the catecholamines from nicotine-stimulated cells; however, piperoxan alone has no effect upon on release from cells not exposed to nicotine. The final exposure to nicotine (Fig.  3) shows that both the cell and the microelectrode still responded to nicotine stimulation and the presence of catecholamines, respectively. Thus, the lack of release for piperoxan exposures labeled d-f in Figure 3 can be attributed to a lack of stimulation of the nicotinic receptors.
The effect of clonidine on stimulated release (Fig. 5 ) further suggests that there are autoreceptors on adrenal medullary chromaffin cells. After the cell is incubated with clonidine, the total catecholamine release declines significantly after the first 3 set application of nicotine. Apparently, the release ofcatecholamine is inhibited by autoreceptors activated by clonidine. The decrease of catecholamine release after incubation of cells with clonidine for 90 min compared to control group is greater (82%) than the decrease after incubation of cells for 30-60 min (75%). This suggests that the effect of clonidine is slow and agrees with the hypothesis that clonidine stimulation of autoreceptors results in the inhibition of catecholamine synthesis (Feldman and Quenzer, 1984) .
Perhaps the most widely known sympathomimetic drug is amphetamine. The actions of amphetamine appear to be manifested as an increased level of extracellular catecholamine in regions of the CNS (Zetterstrom et al., 1983; Hernandez et al., 1987; Sharp et al., 1987) . A great deal of work has shown that amphetamine enhances release of catecholamines (Kuczenski, 1983) , inhibits the catecholamine transporter (Wise and Bozarth, 1987) and accelerates exchange diffusion across the plasma membrane (Fischer and Cho, 1979; Kuczenski, 1983) . In addition, recent evidence suggests that amphetamine acts as a weak base to disrupt catecholamine vesicularization, and therefore enhance the cytoplasmic level of neurotransmitter for subsequent release via reverse transport (Sulzer and Rayport, 1990) . All these actions appear to play a role in the response to amphetamine. The data presented in this article point to a specific mechanism whereby amphetamine can also increase extracellular catecholamine levels via an increase in exocytotic release by acting as an antagonist on a,-autoreceptors. This appears to be completely consistent with data suggesting that amphetamine does not bind strongly to the catecholamine transporter (Andersen, 1987; Ritz et al., 1987) . However, the data are not consistent with studies showing an effect of amphetamine due to binding at dopamine receptors (Shalaby et al., 1983; Kuczenski et al., 1990) . This might reflect a specific difference in action between D, and a,-autoreceptors. Blockade of cu,-autoreceptors leading to enhanced release increases the extracellular level of catecholamine, which is the clear end result of amphetamine administration.
